Glecepravir-pibrentasvir
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Glecepravir-pibrentasvir, covering 2024-03-06 to 2024-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvir [Phase 4]